Blood Product Replacement in the Perinatal Period

Yan Yun Wu, Gary Stack

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Objective: In this article, we will describe some of the special compatibility testing procedures and blood component preparation and modification techniques used in intrauterine and neonatal transfusion medicine. We also will review the transfusion therapy used in hemolytic disease of the fetus and newborn (HDFN) and fetal and neonatal alloimmune thrombocytopenia (FNAIT). Finding: Transfusion therapy in the fetus and neonate requires blood typing and compatibility testing techniques not routinely used for adults. These include: cord blood testing, special attention to the volume and speed of infusion, cytomegalovirus risk reduction, and routine irradiation of cellular blood components. The treatment of HDFN and FNAIT involves phenotyping and/or genotyping of fetal and paternal red blood cells and platelets. In FNAIT, platelet products are chosen based on the absence of platelet-specific antigens. Conclusion: Fetal and neonatal transfusion medicine require special attention to the unique anatomic and physiologic features of early human development.

Original languageEnglish (US)
Pages (from-to)262-271
Number of pages10
JournalSeminars in Perinatology
Issue number4
StatePublished - 2007
Externally publishedYes


  • blood components
  • hemolytic disease of the newborn
  • neonatal alloimmune thrombocytopenia
  • perinatal transfusion
  • transfusion

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology


Dive into the research topics of 'Blood Product Replacement in the Perinatal Period'. Together they form a unique fingerprint.

Cite this